Dr. Wei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Sumc-Peds Physician Billing Mc:5530
Stanford, CA 94305Phone+1 650-498-7391Fax+1 650-725-7888
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2002 - 2005
- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2005 - 2026
Publications & Presentations
PubMed
- 22 citationsPhase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers.Komal Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella
Clinical Cancer Research. 2021-01-15 - 25 citationsHigh-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells.Johan Jeong, Astraea Jager, Pablo Domizi, Mara Pavel-Dinu, Linda Gojenola
Blood Advances. 2019-10-08 - 3 citationsA phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients wit...Vandana G Abramson, Mafalda Oliveira, Andrés Cervantes, Hans Wildiers, Manish R. Patel
Breast Cancer Research and Treatment. 2019-07-31
Abstracts/Posters
- An Individualized Risk Mitigation Approach for Safety: Experience from the Mosunetuzumab (CD20/CD3 Bispecific Antibody) Development Program in Relation to Neurotoxicit...Michael C Wei, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin LymphomaMichael C Wei, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Michael J. Wei, DDS Named New York Top Doctor in General and Cosmetic Dentistry for 2019July 19th, 2019
- Dr. Michael J. Wei, NYC Dentist, Named New York Top Dentist for 2019February 28th, 2019
- Midtown Manhattan Cosmetic Dentist Dr. Michael J. Wei Attends 34th American Academy of Cosmetic Dentistry ConferenceAugust 8th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: